Precision Dose Inc. is recalling approximately 224,940 unit dose cups of Ranitidine Oral Solution, USP, 150 mg/10 mL. This prescription medication, commonly used to treat acid reflux and ulcers, was found to contain an impurity called N-nitrosodimethylamine (NDMA). The recall affects multiple batches distributed nationwide in the United States and specifically involves the 10 mL unit dose cups used in clinical and hospital settings.
NDMA is classified as a probable human carcinogen based on results from laboratory tests. While it is a known environmental contaminant found in water and foods, the presence of this impurity in the drug's active ingredient exceeds acceptable safety levels, potentially increasing the risk of cancer over long-term exposure.
Healthcare provider consultation and pharmacy refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.